The listing below shows our latest News Items and is updated regularly. If you wish to post a news item please select the 'Post News' button on the right. The displayed news feed starts on 1st August 2016. Older items can be found here.
To 'Post Your News' use the button at the top right.
We are pleased to present below all posts archived in 'January, 2020'. If you still can't find what you are looking for, try using the search box.
AMSBIO announces a Custom Chimeric Antigen Receptor T cell (CAR-T) service designed to take advantage of the astonishing clinical breakthroughs achieved with CAR-T cells in various hematological malignancies.
Read the rest of entry »
Medical research charity Orthopaedic Research UK (ORUK) has announced that biotech start-up, Renovos, will receive the first investment from its newly launched the Ronald Furlong Fund, a partnership between ORUK and HS., established this year in memory of the charity’s founder.
An Australian hospital has become the first in the world to use wireless monitoring technology hospital-wide, revolutionising its approach to the most basic process in healthcare – taking and recording patients’ vital signs.
Innovate UK fund cutting-edge projects via their Smart Grant Competitions. With multiple deadlines a year, these competitions give businesses from all industry sectors the opportunity to submit their innovative project ideas, to be awarded up to £2 million in Grant Funding.
Arecor Limited, the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces Dr Jan Jezek, Chief Scientific Officer, will present at PEPTalk 2020, in San Diego, California, USA on 20-24 January 2020.
The Oxford Science Park sponsors the OXBA Innovation Award for the fifth year . Apply now to join previous winners such as 2019’s Oxford Biomedica
Exonate Announces Collaboration with Janssen to develop a new eye drop for the treatment of retinal vascular diseases including wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO)
VivoPlex Group Ltd, which is transforming fertility treatment with precision medicine, has expanded to take on laboratory and office premises on Milton Park, Oxford.
Oxford, UK – 9th January 2020 – Grey Wolf Therapeutics, a drug discovery biotechnology company focused on developing first-in-class therapies for immuno-oncology (IO), today announces it has completed a £2.5 million ($3.3 million) Series A2 financing round with existing leading international healthcare investors Andera Partners and Canaan.
Hikma Pharmaceuticals PLC (Hikma, Group / LSE: HIK / NASDAQ Dubai: HIK / OTC: HKMPY) (rated Ba1/stable Moody’s and BB+/positive S&P), the multinational generic pharmaceutical company, and Arecor Ltd, the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announce they have entered into an exclusive agreement to co-develop a new, ready-to-use injectable medicine in the US through Hikma’s affiliate, Hikma Pharmaceuticals USA Inc.
OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.